Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer

Figure 1

The 1-year overall survival rate and median survival time of all ATC patients were 3.5% (95% CI: 1.7–8.0) and 77 days (95% CI: 57–88), respectively (a). However, 16 ATC patients had insufficient data to classify the staging and modality of treatment. Thus, 105 ATC patients showed a 1-year overall survival rate of 4% (95% CI: 1.3–9.2) and a median survival time of 82 days (95% CI: 63–96) (b).

(a)

(b)